TORONTO, ON — PR Associates National Communications Ltd. (PR Associates), a premier Canadian public relations firm, is pleased to announce the appointment of Michael MacMillan as Vice-President of Client Services…. Read More
Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023 Progress preclinical research in glaucoma in preparation for human trials Advance research using rare cannabinoids in treating neurodegenerative… Read More
First iPSC-derived commercially viable off-the-shelf islet combination product is advancing towards regulatory filing in 2024 for anticipated clinical trial authorization to treat patients with Type 1 Diabetes (T1D) and severe… Read More
From a single blood draw, patients receive a comprehensive health assessment and a tailored action plan to help reduce their disease risks. VANCOUVER, BC — Molecular You announced the launch… Read More
The first-in-Canada Ethos radiation therapy unit uses artificial intelligence to customize treatment Patients receiving cancer care in Kelowna are the first in Canada to receive advanced radiation therapy using the… Read More
